These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 6662171)
1. The antiarrhythmic effects of controlled release disopyramide phosphate and long acting propranolol in patients with ventricular arrhythmias. Fechter P; Ha HR; Follath F; Nager F Eur J Clin Pharmacol; 1983; 25(6):729-34. PubMed ID: 6662171 [TBL] [Abstract][Full Text] [Related]
2. [Antiarrhythmic effect of disopyramid retard versus propranolol retard in ventricular extrasystole]. Fechter P; Nager F Schweiz Med Wochenschr; 1982 Dec; 112(51):1897-900. PubMed ID: 6187065 [TBL] [Abstract][Full Text] [Related]
3. Antiarrhythmic efficacy of Ethmozine (moricizine HCl) compared with disopyramide and propranolol. Pratt CM; Butman SM; Young JB; Knoll M; English LD Am J Cardiol; 1987 Oct; 60(11):52F-58F. PubMed ID: 3310586 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of and adverse effects of disopyramide. Comparison of capsules, controlled release tablets and placebo in patients with chronic ventricular arrhythmias. Ekelund LG; Nilsson E; Walldius G Eur J Clin Pharmacol; 1986; 29(6):673-7. PubMed ID: 3519236 [TBL] [Abstract][Full Text] [Related]
5. [Therapy of ventricular tachyarrhythmia with disopyramid phosphate]. Steinbrunn W; Mattmann H; Enrico JF; Engel U Schweiz Med Wochenschr; 1980 Jun; 110(24):953-7. PubMed ID: 7414314 [TBL] [Abstract][Full Text] [Related]
6. Dihydroquinidine versus disopyramide: efficacy in patients with chronic stable ventricular ectopy. Chimienti M; Panciroli C; Salerno JA; Regazzi-Bonora M; Previtali M; Cristiani D; Rondanelli R; Bobba P Clin Cardiol; 1984 Oct; 7(10):538-46. PubMed ID: 6386253 [TBL] [Abstract][Full Text] [Related]
7. [Delayed-action disopyramide in the treatment of hyperkinetic ventricular arrhythmia. A randomized clinical comparative study vs immediate-action disopyramide]. Romanò M; Spinelli A; Cazzani E; Muzio L Clin Ter; 1991 Jul; 138(1):13-9. PubMed ID: 1834395 [TBL] [Abstract][Full Text] [Related]
9. A double-blind, crossover comparison of flecainide acetate and disopyramide phosphate in the treatment of ventricular premature complexes. Kjekshus J; Bathen J; Orning OM; Storstein L Am J Cardiol; 1984 Feb; 53(5):72B-78B. PubMed ID: 6421140 [TBL] [Abstract][Full Text] [Related]
11. [Antiarrhythmic effect of disopyramide in ventricular extrasystole and auricular fibrillation]. Breithardt G; Haerten K; Seipel L Z Kardiol; 1976 Aug; 65(8):713-23. PubMed ID: 61664 [TBL] [Abstract][Full Text] [Related]
12. Prajmalium bitartrate in chronic ventricular arrhythmias: comparison with disopyramide. Chiariello M; Indolfi C; Cappelli Bigazzi M; Condorelli M Eur J Clin Pharmacol; 1983; 24(1):35-9. PubMed ID: 6832199 [TBL] [Abstract][Full Text] [Related]
13. Acute intervention studies in patients with myocardial infarction using atenolol, propranolol, oxprenolol and disopyramide phosphate. Wilcox RG Acta Med Scand Suppl; 1981; 651():193-202. PubMed ID: 6119875 [TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind, parallel group comparison of disopyramide phosphate and quinidine in patients with cardiac arrhythmias. Arif M; Laidlaw JC; Oshrain C; Willis PW; Nissen CH; McDermott DJ; Smith WS; Karim A; Wilson RR Angiology; 1983 Jun; 34(6):393-400. PubMed ID: 6408949 [TBL] [Abstract][Full Text] [Related]
15. [Efficacy and tolerability of sustained-release disopyramide in the treatment of cardiac arrhythmia. Results of a study with 593 patients]. Lekieffre J; Vaur L; Kacet S; Lacroix D Ann Cardiol Angeiol (Paris); 1993 Feb; 42(2):115-9. PubMed ID: 8494319 [TBL] [Abstract][Full Text] [Related]
16. Long-term use of controlled-release disopyramide in patients with severe ventricular arrhythmias. Paulk EA Angiology; 1987 Feb; 38(2 Pt 2):198-204. PubMed ID: 3103494 [TBL] [Abstract][Full Text] [Related]
17. Comparative study of encainide and disopyramide in chronic ventricular arrhythmias: a double-blind placebo-controlled crossover study. Caron JF; Libersa CC; Kher AR; Kacet S; Wanszelbaum H; Dupuis BA; Poirier JM; Lekieffre JP J Am Coll Cardiol; 1985 Jun; 5(6):1457-63. PubMed ID: 2582017 [TBL] [Abstract][Full Text] [Related]
18. Disopyramide in hypertrophic cardiomyopathy. II. Noninvasive assessment after oral administration. Pollick C Am J Cardiol; 1988 Dec; 62(17):1252-5. PubMed ID: 3057852 [TBL] [Abstract][Full Text] [Related]
19. Propafenone versus disopyramide for treatment of chronic symptomatic ventricular arrhythmias. A multicenter study. Jonason T; Ringqvist I; Bandh S; Nilsson G; Nilsson H; Lidell C; Bjerle P; Olofsson BO Acta Med Scand; 1988; 223(6):515-23. PubMed ID: 3291557 [TBL] [Abstract][Full Text] [Related]
20. Plasma levels of disopyramide after administration of conventional capsules and sustained-release tablets. Nauta IL; van de Calseyde J; Hertzberger DP Curr Med Res Opin; 1983; 8(8):582-93. PubMed ID: 6653136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]